Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
77.49
+4.16 (5.67%)
At close: Jun 9, 2026, 4:00 PM EDT
75.31
-2.18 (-2.81%)
Pre-market: Jun 10, 2026, 6:23 AM EDT
Corcept Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Corcept Therapeutics stock has a consensus rating of "Buy" and an average price target of $88. The average 1-year stock price forecast is 13.56% higher than the current stock price, while the lowest is $50 (-35.48%) and the highest is $135 (+74.22%).
Price Target: $88 (+13.56%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Corcept Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $88 | Buy | Reiterates | $88 | +13.56% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $95 | Buy | Reiterates | $95 | +22.60% | Jun 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $110 → $135 | Buy | Reiterates | $110 → $135 | +74.22% | May 28, 2026 |
| UBS | UBS | Buy Upgrades $72 | Buy | Upgrades | $72 | -7.08% | May 13, 2026 |
| Wolfe Research | Wolfe Research | Hold Upgrades n/a | Hold | Upgrades | n/a | n/a | Mar 26, 2026 |
Financial Forecast
Revenue This Year
988.62M
from 761.41M
Increased by 29.84%
Revenue Next Year
1.40B
from 988.62M
Increased by 41.62%
EPS This Year
0.49
from 0.82
Decreased by -40.55%
EPS Next Year
2.50
from 0.49
Increased by 411.79%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0B | ||
| Avg | 988.6M | ||
| Low | 918.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 34.7% | ||
| Avg | 29.8% | ||
| Low | 20.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.49 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -40.5% | ||
| Low | - |